Robert J. Bitterman - Sep 11, 2024 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Chairman, Pres & CEO, Director
Signature
/s/ Robert M. Infarinato, Attorney-in-Fact
Stock symbol
PHIO
Transactions as of
Sep 11, 2024
Transactions value $
$0
Form type
4
Date filed
9/13/2024, 02:59 PM
Previous filing
Jun 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common Stock, $0.0001 par value Award $0 +15.5K +664.67% $0.00 17.8K Sep 11, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying a restricted stock unit, which shares will vest in one year on the first anniversary.
F2 Includes shares of common stock underlying unvested restricted stock units.